PKBDS6778XLCV
File Set Type
intermediate analysis
Publication Identifiers
Description
Analysis set of EndoC-bH3 cells treated with 4-hydroxy tamoxifen for three weeks from GSE207816
SamplesReport view
1 item
Accession
Type
Sample Terms
Summary
HumanBetaCellLines
EndoC-bH3 cell line, treated with 1 mM 4-hydroxy tamoxifen for 21 days
Donors
1 item
Files
16 items
bam
transcriptome alignments
March 3, 2026
validated
bam
alignments
March 3, 2026
validated
bam
alignments
March 3, 2026
validated
txt
QC metrics
March 3, 2026
validated
tsv
element quantifications
March 3, 2026
validated
bam
transcriptome alignments
March 3, 2026
validated
tsv
element quantifications
March 3, 2026
validated
tsv
QC metrics
March 3, 2026
validated
tsv
element quantifications
March 3, 2026
validated
tsv
QC metrics
March 3, 2026
validated
Attribution
Funding
Supported by National Institutes of Health (NIH) grants U24 DK138515, U24 DK138512
Supplemental funds from the NIH Office of Data Science Strategies
Supplemental funds from the NIH Office of Data Science Strategies
